Etiology, Epidemiology and treatment of bacterial pharyngitis: a review article

Abstract

Pharyngitis is an upper respiratory tract condition common in both general and specialist clinics. Though the majority of cases are viral, bacterial pharyngitis led by Streptococcus pyogenes (group A streptococcus) still forms a major percentage of infections with a risk for severe complications like rheumatic fever and peritonsillar abscesses. Knowledge of the pathogens, epidemiological trends, and treatment strategies would ensure optimal care and prevent antibiotic misuse. The purpose of this review is to describe what is currently known about the bacterial etiologies of pharyngitis while narrowing the more likely causative organisms—Streptococcus pyogenes, Mycoplasma pneumoniae, and Fusobacterium necrophorum. It then discusses global and regional epidemiological trends plus how age, seasonal timing, and socioeconomic status factor into disease prevalence. This paper reviews treatment strategies. It discusses the use of empiric antibiotics based on evidence, antimicrobial resistance, clinical scoring systems, and rapid diagnostics in guiding treatment. Antimicrobial resistance is a global problem increasingly pressing that has not left bacterial pharyngitis untouched as timely and adequate management depend on accurate diagnosis. Thus, recent evidence consolidated here offers clinicians as well as investigators an updated comprehensive insight into bacterial pharyngitis toward improved disease targeting through enhanced precision in diagnosis and appropriate therapeutic decision-making besides public health measures in transmission control and antimicrobial resistance.

Keywords:

Etiology, Epidemiology, treatment, bacterial pharyngitis

References

Atkinson, T. P., Balish, M. F., & Waites, K. B. (2008). Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiology Reviews, 32(6), 956–973. https://doi.org/10.1111/j.1574-6976.2008.00129.x

Bisno, A. L., Gerber, M. A., Gwaltney, J. M., Kaplan, E. L., & Schwartz, R. H. (2002). Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clinical Infectious Diseases, 35(2), 113–125. https://doi.org/10.1086/340949

Brink, A. J., Botha, R. F., Poswa, X. M., Senekal, M., Badat, R., & Moodley, M. (2008). Group C Streptococcus pharyngitis. Southern African Journal of Epidemiology and Infection, 23(4), 16–18.

Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005). The global burden of group A streptococcal diseases. The Lancet Infectious Diseases, 5(11), 685–694. https://doi.org/10.1016/S1473-3099(05)70267-X

Centor, R. M., Atkinson, T. P., Ratliff, A. E., Xiao, L., & Waites, K. B. (2015). The clinical presentation of Fusobacterium necrophorum pharyngitis in a university health clinic. Open Forum Infectious Diseases, 2(2), ofv011. https://doi.org/10.1093/ofid/ofv011

Cohen, J. F., Bertille, N., Cohen, R., & Chalumeau, M. (2016). Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database of Systematic Reviews, 7, CD010502. https://doi.org/10.1002/14651858.CD010502.pub2

Cunningham, M. W. (2000). Pathogenesis of group A streptococcal infections. Clinical Microbiology Reviews, 13(3), 470–511. https://doi.org/10.1128/CMR.13.3.470-511.2000

Eilbert, W. P., & Singla, N. (2013). Lemierre's syndrome. International Journal of Emergency Medicine, 6, 40. https://doi.org/10.1186/1865-1380-6-40

Gerber, M. A., & Shulman, S. T. (2004). Rapid diagnosis of pharyngitis caused by group A streptococci. Clinical microbiology reviews, 17(3), 571–580. https://doi.org/10.1128/CMR.17.3.571-580.2004

Gerber, M. A., Baltimore, R. S., Eaton, C. B., Gewitz, M., Rowley, A. H., Shulman, S. T., ... & Taubert, K. A. (2009). Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis. Circulation, 119(11), 1541–1551. https://doi.org/10.1161/CIRCULATIONAHA.109.191959

Hayward, G. N., Thompson, M. J., Perera, R., Glasziou, P. P., Del Mar, C. B., Heneghan, C. J., & Mant, D. (2017). Corticosteroids as adjunctive therapy for sore throat: A systematic review and meta-analysis. BMJ, 358, j3887. https://doi.org/10.1136/bmj.j3887

Lind, K. (1992). Arcanobacterium haemolyticum: An emerging pathogen. Clinical Infectious Diseases, 14(4), 1040–1048. https://doi.org/10.1093/clinids/14.4.1040

Linder, J. A., Bates, D. W., Lee, G. M., & Finkelstein, J. A. (2005). Antibiotic treatment of children with sore throat. JAMA, 294(18), 2315–2322. https://doi.org/10.1001/jama.294.18.2315

Magdefrau, A. M., Kathner Schaffert, C., Jena University Hospital, … InfectoGnostics Research Campus. (2025). Point-of-care testing cuts antibiotic use in pharyngitis: A meta-analysis of randomized controlled trials. Open Forum Infectious Diseases. Advance online publication.

Pfoh, E., Wessels, M. R., & Goldmann, D. (2008). Burden and economic cost of group A streptococcal pharyngitis. Pediatrics, 121(2), 229–234. https://doi.org/10.1542/peds.2007-0793

Seckeler, M. D., & Hoke, T. R. (2011). The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clinical Epidemiology, 3, 67–84. https://doi.org/10.2147/CLEP.S12977

Shulman, S. T., Bisno, A. L., Clegg, H. W., Gerber, M. A., Kaplan, E. L., Lee, G., ... & Van Beneden, C. (2012). Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis. Clinical Infectious Diseases, 55(10), 1279–1282. https://doi.org/10.1093/cid/cis847

StatPearls. (2024). Bacterial pharyngitis. In StatPearls [Internet]. StatPearls Publishing. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK559007/

Turner, C. E., Abbott, J., Lamagni, T., Holden, M. T., David, S., Jones, M. D., ... & Sriskandan, S. (2012). Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom. mBio, 6(4), e00622-15. https://doi.org/10.1128/mBio.00622-15

Uyeki, T. M., Bernstein, H. H., Bradley, J. S., Englund, J. A., File, T. M., Fry, A. M., & Pavia, A. T. (2019). Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clinical Infectious Diseases, 68(6), e1–e47. https://doi.org/10.1093/cid/ciy866

Vos, T., Lim, S. S., Abbafati, C., et al. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9

Wagner, K. S., White, J. M., Neal, S., Crowcroft, N. S., Kupreviciene, N., Paberza, R., ... & Efstratiou, A. (2010). Diphtheria in the postepidemic period, Europe, 2000–2009. Emerging Infectious Diseases, 18(2), 217–225. https://doi.org/10.3201/eid1802.110987

World Health Organization (WHO). (2021). Antimicrobial resistance. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance